Laurus Labs Limited (BOM:540222)
1,004.95
+16.20 (1.64%)
At close: Jan 22, 2026
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 548.71 billion as of January 23, 2026. Its market cap has increased by 69.72% in one year.
Market Cap
548.71B
Enterprise Value
571.48B
Revenue
67.48B
Ranking
n/a
PE Ratio
65.07
Stock Price
1,004.95
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 548.71B, an increase of 1,056.69%. That is a compound annual growth rate of 30.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 548.71B | -8.27% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 168.94B |
| Sudeep Pharma | 60.82B |
| Shilpa Medicare | 54.48B |
| Gujarat Themis Biosyn | 36.48B |
| Suven Life Sciences | 30.77B |
| IOL Chemicals and Pharmaceuticals | 21.01B |
| Bajaj HealthCare | 11.56B |
| NGL Fine-Chem | 9.43B |